Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 86
- +5 vs. Q2 2023
- Portfolio value
- $3.16B
- +$103.9M (+3.4%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRUSMerus N.V. | COM | 1,901,337 | $0 | 0.0% | +358,175+23.2% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 967,690 | $5.27M | 0.2% | +319,239+49.2% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 1,249,900 | $6.00M | 0.2% | 00.0% | Unchanged | History |
| RYZBRayzeBio, Inc. | COM | 277,778 | $6.17M | 0.2% | +277,778 | New | History |
| AGENAgenus Inc | COM NEW | 6,307,030 | $7.13M | 0.2% | +1,609,100+34.3% | Added | History |
| REPLReplimune Group, Inc. | COM | 487,520 | $8.34M | 0.3% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 77,497 | $8.99M | 0.3% | −163,902−67.9% | Reduced | History |
| SGENSeagen Inc. | COM | 42,497 | $9.02M | 0.3% | 00.0% | Unchanged | History |
| AMGNAmgen Inc | Stock | 36,200 | $9.73M | 0.3% | +36,200 | New | History |
| SKINSkinHealth Systems Inc. | COM CL A | 1,626,236 | $9.79M | 0.3% | +1,626,236 | New | History |
| LUNGPulmonx Corp | COM | 988,559 | $10.2M | 0.3% | −10,803−1.1% | Reduced | History |
| APGEApogee Therapeutics, Inc. | COM | 491,113 | $10.5M | 0.3% | +491,113 | New | History |
| THRDThird Harmonic Bio, Inc. | COM | 1,653,991 | $10.6M | 0.3% | +1,653,991 | New | History |
| PRCTPROCEPT BioRobotics Corp | COM | 331,061 | $10.9M | 0.3% | +331,061 | New | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,038,310 | $11.6M | 0.4% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 5,954,273 | $11.7M | 0.4% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 1,348,099 | $13.0M | 0.4% | +1,348,099 | New | History |
| Integra Lifesciences Hldgs C457985AM1 | NOTE 0.500% 8/1 | – | $13.3M | 0.4% | – | – | – |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,840,052 | $14.3M | 0.5% | +997,700+54.2% | Added | History |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $14.9M | 0.5% | – | – | – |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $15.1M | 0.5% | – | New | – |
| DYNDyne Therapeutics, Inc. | COM | 1,821,972 | $16.3M | 0.5% | +444,100+32.2% | Added | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 12,107,785 | $16.5M | 0.5% | 00.0% | Unchanged | History |
| TMDXTransMedics Group, Inc. | COM | 307,200 | $16.8M | 0.5% | +307,200 | New | History |
| INCYIncyte Corp | COM | 294,900 | $17.0M | 0.5% | +294,900 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,908,865 | $17.3M | 0.5% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,082,512 | $18.0M | 0.6% | +98,112+10.0% | Added | History |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $18.4M | 0.6% | – | – | – |
| PTGXProtagonist Therapeutics, Inc | COM | 1,109,150 | $18.5M | 0.6% | +1,109,150 | New | History |
| RGENRepligen Corp | COM | 118,400 | $18.8M | 0.6% | +26,400+28.7% | Added | History |
| ANABAnaptysbio, Inc | COM | 1,049,823 | $18.9M | 0.6% | −104,600−9.1% | Reduced | History |
| DHRDanaher Corp | Stock | 77,200 | $19.2M | 0.6% | +21,800+39.4% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 2,023,900 | $19.2M | 0.6% | +1,473,600+267.8% | Added | History |
| HLVXHilleVax, Inc. | COM | 1,449,246 | $19.5M | 0.6% | +200,000+16.0% | Added | History |
| AXNXAxonics, Inc. | COM | 354,527 | $19.9M | 0.6% | −219,264−38.2% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 100,300 | $19.9M | 0.6% | +100,300 | New | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $20.0M | 0.6% | – | – | – |
| LNTHLantheus Holdings, Inc. | Stock | 288,300 | $20.0M | 0.6% | +288,300 | New | History |
| GHGuardant Health, Inc. | COM | 689,000 | $20.4M | 0.6% | +419,000+155.2% | Added | History |
| PENPenumbra Inc | COM | 95,315 | $23.1M | 0.7% | +29,471+44.8% | Added | History |
| ETNB89bio, Inc. | COM | 1,590,387 | $24.6M | 0.8% | +1,590,387 | New | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,289,872 | $25.9M | 0.8% | +1,289,872 | New | History |
| HROWHarrow, Inc. | COM | 1,808,684 | $26.0M | 0.8% | +356,146+24.5% | Added | History |
| OMOutset Medical, Inc. | COM | 2,400,427 | $26.1M | 0.8% | +940,059+64.4% | Added | History |
| Neogenomics Inc64049MAA8 | NOTE 1.250% 5/0 | – | $26.3M | 0.8% | – | – | – |
| ALECAlector, Inc. | COM | 4,074,120 | $26.4M | 0.8% | −57,195−1.4% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,735,182 | $26.6M | 0.8% | +528,882+43.8% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 114,920 | $33.6M | 1.1% | −8,900−7.2% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 1,057,770 | $33.8M | 1.1% | +296,562+39.0% | Added | History |
| NVRONevro Corp | COM | 1,776,368 | $34.1M | 1.1% | 00.0% | Unchanged | History |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $35.5M | 1.1% | – | New | – |
| Ironwood Pharmaceuticals Inc46333XAF5 | NOTE 0.750% 6/1 | – | $37.3M | 1.2% | – | New | – |
| BCRXBiocryst Pharmaceuticals Inc | COM | 5,362,980 | $38.0M | 1.2% | +2,571,100+92.1% | Added | History |
| ALGNAlign Technology Inc | COM | 125,213 | $38.2M | 1.2% | −98,817−44.1% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 75,749 | $38.3M | 1.2% | +48,449+177.5% | Added | History |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $39.7M | 1.3% | – | – | – |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 3,974,857 | $39.7M | 1.3% | +2,170,157+120.3% | Added | History |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $40.9M | 1.3% | – | – | – |
| FNAParagon 28, Inc. | COM | 3,361,824 | $42.2M | 1.3% | +1,225,702+57.4% | Added | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 3,336,221 | $42.4M | 1.3% | −310,198−8.5% | Reduced | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $43.1M | 1.4% | – | – | – |
| KROSKeros Therapeutics, Inc. | COM | 1,357,309 | $43.3M | 1.4% | +213,444+18.7% | Added | History |
| NTRANatera, Inc. | COM | 1,012,145 | $44.8M | 1.4% | −140,706−12.2% | Reduced | History |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $45.2M | 1.4% | – | – | – |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 3,715,573 | $45.6M | 1.4% | +353,760+10.5% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 906,973 | $47.1M | 1.5% | +438,946+93.8% | Added | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $48.2M | 1.5% | – | – | – |
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | – | $49.5M | 1.6% | – | New | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $50.5M | 1.6% | – | – | – |
| Ionis Pharmaceuticals Inc462222AD2 | NOTE 4/0 | – | $51.8M | 1.6% | – | – | – |
| GKOSGLAUKOS Corp | COM | 695,792 | $52.4M | 1.7% | −348,600−33.4% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 568,157 | $53.6M | 1.7% | +89,600+18.7% | Added | History |
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $53.6M | 1.7% | – | New | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $56.6M | 1.8% | – | – | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 879,564 | $59.1M | 1.9% | +323,263+58.1% | Added | History |
| BSXBoston Scientific Corp | Stock | 1,164,850 | $61.5M | 1.9% | +447,800+62.5% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 2,103,396 | $71.9M | 2.3% | +275,043+15.0% | Added | History |
| PCVXVaxcyte, Inc. | COM | 1,619,553 | $82.6M | 2.6% | −102,800−6.0% | Reduced | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $102.0M | 3.2% | – | – | – |
| NBIXNeurocrine Biosciences Inc | Stock | 968,024 | $108.9M | 3.4% | +34,662+3.7% | Added | History |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $109.8M | 3.5% | – | – | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $112.4M | 3.6% | – | – | – |
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $113.7M | 3.6% | – | – | – |
| Ascendis Pharma A/S04351PAD3 | NOTE 2.250% 4/0 | – | $113.8M | 3.6% | – | – | – |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $118.0M | 3.7% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $185.8M | 5.9% | – | – | – |
Sold out since Q2 2023 (14)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 1,029,901 | $47.8M | 1.6% | History |
| BIIBBiogen Inc. | COM | 121,942 | $34.7M | 1.1% | History |
| ACRSAclaris Therapeutics, Inc. | COM | 2,901,194 | $30.1M | 1.0% | History |
| Amyris, Inc.03236MAJ0 | NOTE 1.500%11/1 | – | $26.2M | 0.9% | – |
| Illumina, Inc.452327AK5 | NOTE 8/1 | – | $22.6M | 0.7% | – |
| VIRVir Biotechnology, Inc. | COM | 728,549 | $17.9M | 0.6% | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 843,087 | $13.9M | 0.5% | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 650,312 | $11.7M | 0.4% | History |
| SLRNACELYRIN, Inc. | COM | 500,000 | $10.4M | 0.3% | History |
| MRTXMirati Therapeutics, Inc. | COM | 240,625 | $8.69M | 0.3% | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,122,900 | $7.42M | 0.2% | History |
| INSMED Inc457669AB5 | NOTE 0.750% 6/0 | – | $2.95M | 0.1% | – |
| ESPREsperion Therapeutics, Inc. | COM | 895,949 | $1.25M | <0.1% | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 25,431 | $457.2K | <0.1% | History |